Susan Ballagh

Summary

Affiliation: Eastern Virginia Medical School
Country: USA

Publications

  1. ncbi request reprint Safety of single daily use for one week of C31G HEC gel in women
    S A Ballagh
    Eastern Virginia Medical School, 601 Colley Avenue, Norfolk, VA 23507 1627, USA
    Contraception 66:369-75. 2002
  2. ncbi request reprint A comparison of techniques to assess cervicovaginal irritation and evaluation of the variability between two observers
    Susan A Ballagh
    CONRAD Clinical Research Center, Eastern Virginia Medical School, 601 Colley Avenue, Norfolk, VA 23507, USA
    Contraception 70:241-9. 2004
  3. ncbi request reprint Vaginal rings for menopausal symptom relief
    Susan A Ballagh
    Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, Virginia 23507, USA
    Drugs Aging 21:757-66. 2004
  4. ncbi request reprint Vaginal hormone therapy for urogenital and menopausal symptoms
    Susan A Ballagh
    Department of Obstetrics and Gynecology, Eastern Virginia Medical School, 601 Colley Avenue, Norfolk, VA 23507, USA
    Semin Reprod Med 23:126-40. 2005
  5. ncbi request reprint Factors affecting the reproducibility and validity of colposcopy for product development: review of current literature
    Susan Ballagh
    CONRAD Clinical Research Center, Eastern Virginia Medical School, Norfolk, VA 23507 1627, USA
    J Acquir Immune Defic Syndr 37:S152-5. 2004
  6. doi request reprint Effects of doxycycline on serum and endometrial levels of MMP-2, MMP-9 and TIMP-1 in women using a levonorgestrel-releasing subcutaneous implant
    Shumei Zhao
    Department of Obstetrics and Gynecology, CONRAD Clinical Research Center, Jones Institute for Reproductive Medicine, Eastern Virginia Medical School, Norfolk, VA 23507, USA
    Contraception 79:469-78. 2009
  7. doi request reprint Ovarian activity and safety of a novel levonorgestrel/ethinyl estradiol continuous oral contraceptive regimen
    David F Archer
    CONRAD Clinical Research Center, Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, VA 23507, USA
    Contraception 80:245-53. 2009
  8. doi request reprint Cervicovaginal colposcopic lesions associated with 5 nonoxynol-9 vaginal spermicide formulations
    Bryna Harwood
    Department of Obstetrics and Gynecology, University of Illinois at Chicago College of Medicine, Chicago, IL, USA
    Am J Obstet Gynecol 198:32.e1-7. 2008
  9. doi request reprint A Phase I study of the functional performance, safety and acceptability of the BufferGel Duet
    Susan A Ballagh
    CONRAD Clinical Research Center, Eastern Virginia Medical School Norfolk, VA 23507, USA
    Contraception 77:130-7. 2008
  10. pmc Single and multiple exposure tolerance study of polystyrene sulfonate gel: a phase I safety and colposcopy study
    Christine K Mauck
    CONRAD, Eastern Virginia Medical School, 1611 North Kent Street, Suite 806, Arlington 22209, USA
    Contraception 70:77-83. 2004

Collaborators

Detail Information

Publications20

  1. ncbi request reprint Safety of single daily use for one week of C31G HEC gel in women
    S A Ballagh
    Eastern Virginia Medical School, 601 Colley Avenue, Norfolk, VA 23507 1627, USA
    Contraception 66:369-75. 2002
    ..Product acceptability of C31G HEC was limited by the sensation of heat or burning. The C31G HEC product had a similar safety profile to N-9 in this comparative trial...
  2. ncbi request reprint A comparison of techniques to assess cervicovaginal irritation and evaluation of the variability between two observers
    Susan A Ballagh
    CONRAD Clinical Research Center, Eastern Virginia Medical School, 601 Colley Avenue, Norfolk, VA 23507, USA
    Contraception 70:241-9. 2004
    ..Colposcopy is used to evaluate effects of new vaginal products on cervicovaginal epithelium as part of the US Food and Drug Administration-mandated product approval process, yet few aspects of its use have been investigated...
  3. ncbi request reprint Vaginal rings for menopausal symptom relief
    Susan A Ballagh
    Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, Virginia 23507, USA
    Drugs Aging 21:757-66. 2004
    ..Vaginal rings offer a novel approach to menopausal hormone therapy producing consistent serum levels sustained for up to 3 months per unit dose with lower adverse effects than other vaginal products and high acceptability among users...
  4. ncbi request reprint Vaginal hormone therapy for urogenital and menopausal symptoms
    Susan A Ballagh
    Department of Obstetrics and Gynecology, Eastern Virginia Medical School, 601 Colley Avenue, Norfolk, VA 23507, USA
    Semin Reprod Med 23:126-40. 2005
    ..The best dose to reduce risk of endometrial pathology adequately in the lower dose therapies will be defined not only by the dose and potency of the exogenous estrogen but by the individual is body habitus and lifestyle choices...
  5. ncbi request reprint Factors affecting the reproducibility and validity of colposcopy for product development: review of current literature
    Susan Ballagh
    CONRAD Clinical Research Center, Eastern Virginia Medical School, Norfolk, VA 23507 1627, USA
    J Acquir Immune Defic Syndr 37:S152-5. 2004
    ..Observers are more likely to agree on areas greater than 1 cm in diameter. Variation is reduced when fewer observers are used and they report findings as dichotomous or categorical data...
  6. doi request reprint Effects of doxycycline on serum and endometrial levels of MMP-2, MMP-9 and TIMP-1 in women using a levonorgestrel-releasing subcutaneous implant
    Shumei Zhao
    Department of Obstetrics and Gynecology, CONRAD Clinical Research Center, Jones Institute for Reproductive Medicine, Eastern Virginia Medical School, Norfolk, VA 23507, USA
    Contraception 79:469-78. 2009
    ..Endometrial spotting and/or bleeding (ESB) occurs in levonorgestrel subcutaneous implant (LNG SI) users. Matrix metalloproteinases (MMPs) may play a role in ESB...
  7. doi request reprint Ovarian activity and safety of a novel levonorgestrel/ethinyl estradiol continuous oral contraceptive regimen
    David F Archer
    CONRAD Clinical Research Center, Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, VA 23507, USA
    Contraception 80:245-53. 2009
    ..A continuous regimen of oral levonorgestrel (LNG) 90 mcg/ethinyl estradiol (EE) 20 mcg was evaluated for inhibition of ovulation, time to return to ovulation after stopping treatment and safety...
  8. doi request reprint Cervicovaginal colposcopic lesions associated with 5 nonoxynol-9 vaginal spermicide formulations
    Bryna Harwood
    Department of Obstetrics and Gynecology, University of Illinois at Chicago College of Medicine, Chicago, IL, USA
    Am J Obstet Gynecol 198:32.e1-7. 2008
    ..This study was undertaken to compare the colposcopic appearance of the cervicovaginal epithelium with spermicide use vs condom use in a low-risk population...
  9. doi request reprint A Phase I study of the functional performance, safety and acceptability of the BufferGel Duet
    Susan A Ballagh
    CONRAD Clinical Research Center, Eastern Virginia Medical School Norfolk, VA 23507, USA
    Contraception 77:130-7. 2008
    ..The purpose of this study was to assess the functional performance of the BufferGel Duet, a buffering microbicide and spermicide gel applied to the cervix and vagina by a novel applicator that also serves as a mechanical barrier...
  10. pmc Single and multiple exposure tolerance study of polystyrene sulfonate gel: a phase I safety and colposcopy study
    Christine K Mauck
    CONRAD, Eastern Virginia Medical School, 1611 North Kent Street, Suite 806, Arlington 22209, USA
    Contraception 70:77-83. 2004
    ..To evaluate symptoms and signs of genital irritation, vaginal leakage and acceptability of polystyrene sulfonate (PSS), which is being studied as a vaginal contraceptive and microbicide...
  11. ncbi request reprint Fourteen-day safety and acceptability study of 6% cellulose sulfate gel: a randomized double-blind Phase I safety study
    Jill L Schwartz
    Department of Obstetrics and Gynecology, CONRAD, Eastern Virginia Medical School, Arlington, VA 22209, USA
    Contraception 74:133-40. 2006
    ..Cellulose sulfate (CS) is a noncytotoxic antifertility agent that exhibits in vitro antimicrobial activity against sexually transmitted pathogens, including HIV...
  12. ncbi request reprint A phase I comparative postcoital testing study of three concentrations of C31G
    Christine K Mauck
    CONRAD, Eastern Virginia Medical School, 1611 North Kent Street, Suite 806, Arlington, VA 22209, USA
    Contraception 70:227-31. 2004
    ..5%, 1.0% and 1.7%, administered as a 3.5-mL dose of a vaginal gel to prevent sperm from entering mid-cycle cervical mucus. Irritation of the genitalia and acceptability were also assessed...
  13. doi request reprint SILCS diaphragm: postcoital testing of a new single-size contraceptive device
    Jill L Schwartz
    CONRAD, Eastern Virginia Medical School, Arlington, VA 22209, USA
    Contraception 78:237-44. 2008
    ..This study was conducted to compare the effectiveness of a new, single-size silicone contraceptive diaphragm used with either spermicide [2% nonoxynol-9 (N-9)] or lubricant in preventing sperm from penetrating midcycle cervical mucus...
  14. doi request reprint A randomized six-day safety study of an antiretroviral microbicide candidate UC781, a non-nucleoside reverse transcriptase inhibitor
    Jill L Schwartz
    CONRAD, Eastern Virginia Medical School, Arlington, Virginia 22209, USA
    Sex Transm Dis 35:414-9. 2008
    ..This study evaluated the effect of a single dose and 5 additional consecutive daily doses of UC781 gel at concentrations of 0.1%, 0.25%, 1.0%, and 0% on urogenital irritation...
  15. doi request reprint Safety analysis of the diaphragm in combination with lubricant or acidifying microbicide gels: effects on markers of inflammation and innate immunity in cervicovaginal fluid
    Deborah J Anderson
    Department of Obstetrics and Gynecology, Boston University School of Medicine, 670 Albany St, Suite 516, Boston, MA 02118, USA
    Am J Reprod Immunol 61:121-9. 2009
    ..The purpose of this study was to determine whether use of a diaphragm with microbicide or placebo gel causes cervicovaginal inflammation or perturbations in cervicovaginal immune defense...
  16. pmc FemCap with removal strap: ease of removal, safety and acceptability
    Christine K Mauck
    CONRAD, Eastern Virginia Medical School, Arlington, VA 22209, USA
    Contraception 73:59-64. 2006
    ..This trial assessed whether the new design reduced removal difficulties and had any effects on dislodgment, genital pain/discomfort, safety, and acceptability...
  17. doi request reprint Six-day randomized safety trial of intravaginal lime juice
    Christine K Mauck
    CONRAD, Eastern Virginia Medical School, Arlington, VA 22209, USA
    J Acquir Immune Defic Syndr 49:243-50. 2008
    ..In vitro data suggest that lime juice is virucidal, but only at cytotoxic concentrations. This is the first controlled, randomized safety trial of lime juice applied to the human vagina...
  18. doi request reprint Multicenter comparison of the contraceptive ring and patch: a randomized controlled trial
    Mitchell D Creinin
    Department of Obstetrics, Gynecology and Reproductive Sciences and Magee Womens Research Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213 3180, USA
    Obstet Gynecol 111:267-77. 2008
    ..To understand if the contraceptive ring or patch was more acceptable, as measured primarily by continuation, to women using an oral contraceptive and interested in a nondaily, combined hormonal contraceptive...
  19. ncbi request reprint Fourteen-day safety and acceptability study of the universal placebo gel
    Jill L Schwartz
    CONRAD, Eastern Virginia Medical School EVMS, Arlington, VA 22209, USA
    Contraception 75:136-41. 2007
    ..This study evaluated the effect of the so-called universal placebo compared to the polystyrene sulfonate (PSS) placebo on genital irritation...
  20. ncbi request reprint Phase I safety trial of two vaginal microbicide gels (Acidform or BufferGel) used with a diaphragm compared to KY jelly used with a diaphragm
    D Nyce L Williams
    CONRAD, Arlington, VA, USA
    Sex Transm Dis 34:977-84. 2007
    ..To assess the safety and acceptability of 2 vaginal microbicide gels (Acidform and BufferGel) used with a diaphragm compared to KY Jelly used with a diaphragm among low-risk, sexually abstinent women...